跳至主要内容
临床试验/IRCT20240411061466N1
IRCT20240411061466N1尚未招募3 期

The effect of vitamin D supplementation along with intravitreal injection of bevacizumab in the treatment of patients with diabetic macular edema and vitamin D deficiency

Kerman University of Medical Sciences0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients with type 2 diabetes and diabetic macular edema
  • Age 18 and above
  • The central thickness of the macula is higher than 300 µm
  • Serum Vitamin D level less than 30 ng/ml

排除标准

  • History of any eye surgery other than uncomplicated cataract surgery at least six months ago
  • History of intravitreal injection of bevacizumab and other anti-VEGF (vascular endothelial growth factor) drugs and steroids during the last three months.
  • History of retinal vascular events
  • History of macular traction , the presence of macular disease due to a cause other than diabetes
  • History of thyroiditis in women, pregnant and lactating women
  • Taking vitamin D supplements at the time of entering the study
  • Severe vitamin D deficiency less than 10 ng/ml
  • Hypercalcemia
  • Hyperphosphatemia
  • Serum creatinine is more than 3 mg/dl

研究者

相似试验

The effect of vitamin D supplementation along with... | 临床试验